Skip to main content

Table 1 Characteristics of patients with arterial AMI

From: Prognostic factors of acute mesenteric ischemia in ICU patients

Characteristics Arterial AMI (n = 214)
Demographics
 Gender, male (%) 51
 Age at diagnosis (years) (mean ± SD) 72 ± 13
 Length of in-hospital stay (days) (median [IQR]) 13 [4–30]
 Length of ICU stay (days) (median [IQR]) 4.5 [2–12]
 In-hospital mortality rate (%) 71
 30-day mortality rate (%) 68
Reason for ICU admission
 Main admission diagnosis (%) 42
 Surgical reason (%) 50
 Urgent reason (%) 90
PMH and comorbidities
 Arterial hypertension (%) 69
 Hypercholesterolemia (%) 47
 Diabetes (%) 20
 Cardiomyopathy (%) 57
 PMH of atrial fibrillation (%) 27
 Peripheral artery disease (%) 44
 PMH of cancer (%) 28
 Chronic inflammatory disease (%) 18
 Hypercoagulability (%) 6
 PMH of surgery (%) 78
Laboratory findings
 CRP (mg/dl) (median [IQR]) 18 [8–25]
 Serum creatinine (mg/dl) (median [IQR]) 2 [1.2–3]
 LDH > 250 IU/l (%) 72
 Leukocytes (× 103/mm3) (median [IQR]) 14.8 [8.8–22]
 Neutrophils (×103/mm3) (median [IQR]) 12.6 [6.6–18]
 Lymphocytes (× 103/mm3) (median [IQR]) 0.83 [0.5–1.18]
 NLR (median [IQR]) 14 [7.7–24]
 INR (median [IQR]) 1.4 [1.1–1.9]
 Platelets 24 h before diagnosis (×103/mm3) (median [IQR]) 157 [88–277]
 Platelets < 100,000/mm3 after diagnosis (%) 59
 Arterial lactate at diagnosis (mmol/l) (median [IQR]) 3.6 [2–7.5]
 Arterial lactate 24 h after diagnosis (mmol/l) (median [IQR]) 3.4 [1.7–8.7]
Diagnostic procedures
 Time from ICU admission to diagnosis (days) (median [IQR]) 1 [0–4]
CT-scan:
 Visualization of vessel obstruction (%) 28
 Hypo-enhancement of bowel wall (%) 64
 Bowel wall thickening (%) 37
 Dilated bowel segment (%) 21
 Fat stranding (%) 2
 Pneumatosis intestinalis (%) 37
 Air in mesenteric vessels (%) 20
 Arteriography performed (%) 8
Laparotomy:
 Not performed (%) 31
 Performed < 24 h post-diagnosis (%) 66
 Performed > 24 h post-diagnosis (%) 3
Autopsy:
 Autopsy performed (%) 17
 Discovery of AMI during autopsy (%) 5
Therapeutic procedures
 Vasopressors in the 24 h preceding diagnosis (%) 51
 Maximal dose of vasopressors (gamma/min) (median [IQR]) 30 [10–53]
 Vasopressors post-diagnosis (%) 81
 Antimicrobial therapy (%) 90
 Anticoagulation (%) 62
 Thrombolysis or embolectomy (%) 5
 Stenting (%) 5
 Laparoscopy (%) 1
 Laparotomy (%) 64
Scores
 SOFA (mean ± SD) 8.7 ± 5
 APACHE II (mean ± SD) 25 ± 10
Comorbidities during ICU stay
 New onset of atrial fibrillation (%) 14
 Acute pancreatitis (%) 8
 Sepsis, septic shock (%) 58
 SCVO2 < 70% or need for inotropic agent (%) 71
 Mechanical ventilation 24 h before diagnosis (%) 47
 RRT after diagnosis (%) 52
 Urine output at ICU admission (ml/24 h) (mean ± SD) 928 ± 1011
 Worst urine output during ICU stay (ml/24 h) (mean ± SD) 321 ± 523
 Urine output at the end of ICU stay (ml/24 h) (mean ± SD) 638 ± 928
 No AKI (%) 22
 RIFLE R, AKIN and KDIGO 1 (%) 10
 RIFLE I, AKIN and KDIGO 2 (%) 10
 RIFLE F/L/E, AKIN and KDIGO 3 (%) 58
  1. AMI acute mesenteric ischemia, SD standard deviation, IQR interquartile range, ICU intensive care unit, PMH prior medical history, NLR neutrophil-to-lymphocyte ratio, RRT renal replacement therapy, AKI acute kidney injury